August 2025 - Page 2 of 4 - BioMedWire (BMW)

ThursdayAug 21, 2025 10:00 am

Scientists Turn Bacteria into Trojan Horses to Deliver Anti-Cancer Viruses into Tumors

Scientists at Columbia University have engineered a cancer treatment that leverages bacteria to smuggle cancer-killing viruses into tumors in a method that sidesteps the defenses of the immune system. This groundbreaking approach utilizes two vital weapons against the cancer; the bacteria are drawn to cancer cells, and the viruses inside the bacteria deliver the killer blow to the tumor cells after being delivered there by the bacteria. The study team was successful in creating built-in safeguards intended to prevent the viruses from infiltrating and infecting tissues outside the tumor environment. Their research promises to introduce a new paradigm in the…

WednesdayAug 20, 2025 11:15 am

Nutriband Inc. (NASDAQ: NTRB): When Regulatory Momentum Meets Leadership Continuity

FDA grants Type C Meeting for AVERSA(TM) Fentanyl to discuss Chemistry, Manufacturing, and Controls pathway from IND submission through NDA approval and commercialization CEO Gareth Sheridan temporarily steps aside to pursue Irish Presidential nomination while Chairman Serguei Melnik assumes interim CEO role during critical development phase Strategic partnership with Kindeva combines proven FDA-approved fentanyl patch technology with Nutriband's proprietary abuse-deterrent platform targeting $80-200 million peak U.S. market opportunity The pharmaceutical development landscape presents a fundamental shift as regulatory frameworks evolve beyond traditional efficacy-first approaches. The most significant patient impact now comes from innovations that enhance safety profiles of existing therapeutic…

TuesdayAug 19, 2025 10:00 am

Young Americans Face Health Insurance Chaos as They Turn 26

As young Americans turn 26, they are faced with a major transition that requires them to find their own health insurance since they no longer qualify to remain on the health insurance plan of their family. As many have found out at this transition point, getting your own insurance is a maze with many twists and turns that can leave one baffled and helpless. How did this transition come about? Back in 2010, the Affordable Care Act was passed and signed into law. This law guaranteed that young people would be assured of having health insurance until they reached the…

TuesdayAug 19, 2025 9:45 am

Lantern Pharma Inc. (NASDAQ: LTRN) Releases Latest AI Breakthrough for Central Nervous System (‘CNS’) Drug Development with predictBBB.ai (TM): A High-Accuracy Open-Access AI Drug Development Tool

Lantern Pharma has publicly launched predictBBB.ai (TM), its AI-driven module for predicting small-molecule blood-brain barrier permeability. The tool achieves 94% prediction accuracy, with 95% sensitivity and 89% specificity, based on real-time ensemble machine learning. Powered by Lantern’s vast molecular features data lake and ensemble algorithms, the platform sets a new computational benchmark for CNS drug discovery. Lantern hosts additional predictive and analytical modules in development, leveraging its large-scale data infrastructure and algorithmic approach. The tool is publicly accessible through a freemium model, aiming to drive adoption, strategic partnerships, and accelerate CNS therapeutic development. Lantern Pharma subsidiary Starlight Therapeutics secures FDA IND clearance…

TuesdayAug 19, 2025 9:45 am

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): How a $500K Device Could Reshape the $8.7 Billion Breast Imaging Market

IzoView Breast CT targets aggressive market displacement with up to 67% lower pricing than competing breast CT systems, positioning at $500K versus competitors priced up to $1.5 million True 360-degree 3D imaging without compression positioned to bridge the clinical gap between standard screening and MRI, offering 100x greater spatial resolution than MRI at significantly lower cost Platform approach enables 14 potential future indications across screening, diagnosis, monitoring, and treatment planning through software upgrades, creating scalable revenue expansion without hardware replacement Every year, outdated imaging technologies underperform for the roughly half of women undergoing breast cancer screening who have dense breast…

FridayAug 15, 2025 12:45 pm

Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy

Ricin toxin is a potent biothreat, so lethal that even a dose the size of a grain of salt can be fatal within 48 to 72 hours. RiVax(R) is a subunit protein vaccine that incorporates Soligenix’s ThermoVax(R) technology, which eliminates the need for cold-chain storage. Soligenix reports that the RiVax antigen has been shown to be safe in phase 1 studies in humans, with future steps including pivotal animal efficacy studies. With global security threats driving demand for advanced biodefense solutions, Soligenix (NASDAQ: SNGX) is advancing RiVax(R), a heat-stable recombinant vaccine candidate aimed at protecting against deadly ricin toxin exposure.…

FridayAug 15, 2025 10:00 am

Study Finds That Low BSA Psoriasis Could Have a High Disease Burden

For decades, the severity of psoriasis has been classified on the basis of thresholds reflecting the BSA, or body surface area, impacted by the condition. Under this classification, individuals with less than 3 percent of BSA were categorized as having mild psoriasis; those with a BSA ranging between 3 and 10 percent were regarded as having moderate psoriasis; while those with a BSA in excess of 10 percent were classified as having severe psoriasis. This way of classifying psoriasis influences the prescription of systemic therapies, particularly biologics indicated for psoriasis. Many insurance firms require that a patient has a BSA…

ThursdayAug 14, 2025 10:00 am

What Women Need to Know About Benign Brain Tumors

It is easy to shrug off forgetfulness or a headache as stress. However, this isn’t always the case as those symptoms could point to the possibility of a tumor in the brain. For women, this risk is even higher given that women make up 62.9% of people who develop noncancerous brain tumors. It is therefore important to know what to look out for, and which steps to take. First, it is important to know that when you are found to have a “benign” tumor in your brain, it doesn’t mean that you are fine. The word benign is used as…

TuesdayAug 12, 2025 10:00 am

Parkinson’s-Gut Bacteria Link Suggests Surprisingly Simple Treatment Option

For long, researchers have posited that a link between our brain and gut contributes to the onset of Parkinson’s disease. Now a new study suggests that B-vitamin supplements could address some of the medical needs of Parkinson’s disease patients after their research linked specific vitamin deficiencies to the disease. Researchers at Nagoya University in Japan, led by Hiroshi Nishiwaki, who conducted the study, suggest that using supplements containing biotin and riboflavin could help in slowing PD progression or at least providing symptomatic relief to patients. Currently, PD doesn’t have a known cure despite approximately 10 million individuals living with the…

FridayAug 08, 2025 10:00 am

Breakthrough Treatment for Lung Cancer Uses Mitochondria to Supercharge Immune Cells

Researchers in China have discovered a way to supercharge the treatment of lung cancer by transplanting mitochondria into the tumor environment. This transplantation increases the effectiveness of chemotherapy while boosting the immune system’s ability to fight the cancer. The team combined cisplatin (a lung cancer chemo drug) with mitochondrial transplantation. Chemotherapy has always been a major part of treating lung cancer. However, this therapy usually compromises immune system function, thereby making long-term cancer suppression challenging since the immune system becomes weak and can’t control the progression of the cancer. By using the new approach, researchers were able to boost immune…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Month: August 2025

Scientists Turn Bacteria into Trojan Horses to Deliver Anti-Cancer Viruses into Tumors

Nutriband Inc. (NASDAQ: NTRB): When Regulatory Momentum Meets Leadership Continuity

Young Americans Face Health Insurance Chaos as They Turn 26

Lantern Pharma Inc. (NASDAQ: LTRN) Releases Latest AI Breakthrough for Central Nervous System (‘CNS’) Drug Development with predictBBB.ai (TM): A High-Accuracy Open-Access AI Drug Development Tool

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): How a $500K Device Could Reshape the $8.7 Billion Breast Imaging Market

Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy

Study Finds That Low BSA Psoriasis Could Have a High Disease Burden

What Women Need to Know About Benign Brain Tumors

Parkinson’s-Gut Bacteria Link Suggests Surprisingly Simple Treatment Option

Breakthrough Treatment for Lung Cancer Uses Mitochondria to Supercharge Immune Cells

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search